LifeScience Alley® and FDA's Devices Center Sign Memorandum of Understanding to Advance Regulatory Science
Published: Dec 08, 2011
MINNEAPOLIS--(BUSINESS WIRE)--LifeScience Alley announced today that it has signed a memorandum of understanding (MOU) with the U.S. Food and Drug Administration's Center for Devices and Radiological Health (CDRH). The MOU formalizes interactions that have been occurring between LifeScience Alley and CDRH for more than a year regarding the advancement of regulatory science. CDRH Director Dr. Jeffrey Shuren signed the MOU today just before his keynote address at the Tenth Annual LifeScience Alley Conference & Expo. Regulatory science refers to the tools, methods, and approaches to assessing the safety, effectiveness, performance, and quality of medical products.